Medtronic : Agreement to Acquire Restore Medical

April 22, 2008 – Medtronic, Inc. (NYSE: MDT) and Restore Medical, Inc. (NASDAQ: REST) announced that the companies have signed a definitive agreement under which Medtronic will pay $1.60 per share in cash for each share of Restore Medical stock. The total value of the transaction, including payment of Restore Medical debt will be approximately $29 million.
The transaction, which is anticipated to close within 90 days, is expected to be accretive to Medtronic earnings in the first full fiscal year after closing. Restore Medical’s Pillar Palatal Implant System (Pillar System) is an innovative, minimally invasive, implantable medical device used to treat the soft palate component of sleep breathing disorders, including mild to moderate obstructive sleep apnea (OSA) and snoring... Medtronic' Press Release -

Efficacy and Benefit of Restore Medical's Pillar(R) Procedure

Sept. 18, 2007--Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal Implant System - a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) - today announced the presentation of positive results from the first U.S. multi-center Level 1 evidence based medicine clinical study of its Pillar palatal implants, which affirmed the efficacy observed in earlier studies in the treatment of mild to moderate OSA... Restore Medica's Press Procedure -

Restore Medical, Clinical Study to Evaluate Pillar Palatal Implants in Combination with Continuous Positive Airway Pressure

Sept. 17, 2007--Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal Implant System - a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) - announced enrollment of the first patients in a clinical study evaluating the use of Pillar palatal implants in combination with continuous positive airway pressure (CPAP) therapy in the treatment of mild to moderate OSA... Restore Medical's Press Release -